ArticleFrontiers in cardiovascular medicine2026
CCTA-derived plaque component-inflammation load is associated with concurrent CT-FFR-defined functional limitation: a retrospective cross-sectional imaging study.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Coronary computed tomography angiography (CCTA) depicts coronary anatomy, plaque composition, and pericoronary inflammation, whereas CT-derived fractional flow reserve (CT-FFR) provides a computational functional estimate. We examined whether a prespecified plaque component-inflammation load (CIL) index was associated with concurrent CT-FFR-defined functional limitation. Methods: This single-center retrospective cross-sectional study included 334 patients (336 vessels or lesions) undergoing clinically indicated CCTA with quantitative plaque analysis, fat attenuation index (FAI) measurement, and CT-FFR computation. The CIL index was the equal-weight mean of standardized lipid component volume, fibrofatty component volume, lipid-to-fibrous ratio, and mean FAI. The primary patient-level endpoint was CT-FFR ≤0.80 in the lesion with the lowest CT-FFR value. Multivariable association, repeated stratified five-fold cross-validation, calibration, bootstrap optimism correction, and prespecified sensitivity analyses were performed. Results: Concurrent CT-FFR ≤0.80 was present in 119 patients (35.6%). A 1-standard-deviation higher CIL index was associated with higher odds of CT-FFR ≤0.80 (adjusted odds ratio 10.60, 95% confidence interval 5.09-22.10; Conclusion: The CIL index was strongly associated with concurrent CT-FFR status within this cohort. Because the index and endpoint were derived from the same CCTA examination, and no external validation, invasive physiological reference, or longitudinal outcomes were available, the results represent within-examination association and internal discrimination rather than independent diagnostic accuracy, prognosis, or established clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.